171 related articles for article (PubMed ID: 12112527)
21. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
22. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis.
Murakami Y
Cancer Sci; 2005 Sep; 96(9):543-52. PubMed ID: 16128739
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status.
Krasteva ME; Bozhanov SS; Antov GG; Gospodinova ZI; Angelov SG
Neoplasma; 2012; 59(1):85-91. PubMed ID: 22103901
[TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells.
Yu J; Zhang Y; Qi Z; Kurtycz D; Vacano G; Patterson D
Gene Expr; 2008; 14(3):173-82. PubMed ID: 18590053
[TBL] [Abstract][Full Text] [Related]
25. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].
Ming S; Gao J; Sun T
Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):464-9. PubMed ID: 20677643
[TBL] [Abstract][Full Text] [Related]
27. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
[TBL] [Abstract][Full Text] [Related]
29. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
30. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
31. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.
Carling T; Du Y; Fang W; Correa P; Huang S
Surgery; 2003 Dec; 134(6):932-9; discussion 939-40. PubMed ID: 14668725
[TBL] [Abstract][Full Text] [Related]
32. Identification of the Tslc1 gene, a mouse orthologue of the human tumor suppressor TSLC1 gene.
Fukami T; Satoh H; Fujita E; Maruyama T; Fukuhara H; Kuramochi M; Takamoto S; Momoi T; Murakami Y
Gene; 2002 Jul; 295(1):7-12. PubMed ID: 12242005
[TBL] [Abstract][Full Text] [Related]
33. Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis.
Gentile M; Ahnström M; Schön F; Wingren S
Oncogene; 2001 Nov; 20(53):7753-60. PubMed ID: 11753653
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation--can this change alone ever designate true tumor suppressor gene function?
Baylin SB; Herman JG
J Natl Cancer Inst; 2001 May; 93(9):664-5. PubMed ID: 11333278
[No Abstract] [Full Text] [Related]
35. Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines.
Kovalev S; Mateen A; Zaika AI; O'Hea BJ; Moll UM
Int J Oncol; 2000 Apr; 16(4):825-31. PubMed ID: 10717253
[TBL] [Abstract][Full Text] [Related]
36. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
37. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
38. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas.
Waha A; Sturne C; Kessler A; Koch A; Kreyer E; Fimmers R; Wiestler OD; von Deimling A; Krebs D; Schmutzler RK
Int J Cancer; 1998 Oct; 78(3):306-9. PubMed ID: 9766563
[TBL] [Abstract][Full Text] [Related]
39. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
[TBL] [Abstract][Full Text] [Related]
40. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
